Floatz logo

Recombinant Human Plasminogen Activator

High Blood Pressure

The George InstitutePhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
89/ 100

Competitive context

17 Active assets in the High Blood Pressure cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
Yuhan Corporation
Phase 4BBB
AMLODIPINE
Yuhan Corporation
Phase 4BBB
Tomato Fruit Extract
Beata Krasinska
Phase 4BB
VALSARTAN
ARKAY Therapeutics
Phase 4BB
Phentermine
VIVUS LLC
Phase 4BB

View all 44 →

Same molecule, other indications

Recombinant Human Plasminogen Activator is also rated in:

stroke disorderDormant
BB
Indicative ·
70 / 100
View asset →
ischemic strokeDormant
BB
Indicative ·
70 / 100
View asset →
brain infarctionDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →